Chronic Pancreatitis, Comorbid with Alcohol Addiction: Epidemiology, Causes, Developmental Features, Symptoms and Supportive Pharmaceutical Therapy
DOI:
https://doi.org/10.53933/sspmpm.v2i2.46Keywords:
chronic pancreatitis, comorbid, alcohol addiction, organization and management of pharmacy, clinical pharmacyAbstract
Chronic pancreatitis is a chronic inflammatory disease of the pancreas, which is accompanied by irreversible structural changes in the development of excretory and incretory insufficiency, manifested by abdominal pain and characterized by a significant reduction in the quality of life of patients. Purpose of the study was to determine the place of alcoholic (toxic) chronic pancreatitis among pancreatitis; to systematize scientific sources on the role of psychoactive substances in the development of comorbid chronic pancreatitis with alcohol addiction. In the period from 1997 to 2021, a review of the scientific literature on the topic of the work was conducted. Depending on the region, up to 70% of acute pancreatitis and up to 90% of chronic pancreatitis cases are alcohol-related psychoactive substances. Alcoholic (toxic) pancreatitis occurs due to exposure of the pancreas to alcohol in up to 80% of all cases. Pharmacotherapy of chronic pancreatitis is important in the context of the spread of coronavirus infection, in most cases conservative, is carried out taking into account the causes and risk factors. Scientific sources on the topic of the work are systematized. Literature data on the epidemiology, causes of chronic pancreatitis and the role of psychoactive substances in the development of chronic pancreatitis were studied.
References
Tukhar I., Shapovalova V., Shapovalov V., Shapovalov V. Pharmacological view on the problem of comorbidity in the pharmacotherapy of chronic pancreatitis. Science Review. Vol. 3. N. 38. P. 1-5. DOI: 10.31435/rsglobal_sr/30072021/7591. DOI: https://doi.org/10.31435/rsglobal_sr/30072021/7591
Löhr J. M. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. United European Gastroenterology Journal. 2017. Vol. 5. N.2. P. 153–199. DOI: http://doi.org/10.1177/2050640616684695. DOI: https://doi.org/10.1177/2050640616684695
Gubergicz N.B. Prakticheskaya pankreatologiya. 2006. P.93-95.
Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. N.1. P.1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37. DOI: https://doi.org/10.53933/sspmpm.v2i1.37
Shapovalov (Jr.) V., Gudzenko A., Shapovalova V. et al. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017. Vol.66. N.3. Р.31–39. URL: http://bsphs.org/wp-content/uploads/2017/11/Shapovalov.pdf.
Hayduchok I., Shapovalov V. Forensic pharmacy and medicine: risks for pharmacotherapy of addiction and countering of illegal circulation of psychoactive substances in the COVID-19 pandemic. 2021. SSP Modern Pharmacy and Medicine. Vol.1. N.2. P.1-28. URL: https://doi.org/10.53933/sspmpm.v1i2.32. DOI: https://doi.org/10.53933/sspmpm.v1i2.32
Chuiev Y., Shapovalova V. Interdisciplinary pharmacoeconomic study of pharmacotherapy of cupping of drunk forms of alcohol dependence: clinical and pharmacological, organizational, legal and marketing experiment. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N. 2. P. 1–12. URL: https://doi.org/10.53933/sspmpm.v1i2.24. DOI: https://doi.org/10.53933/sspmpm.v1i2.24
Yabluchanskij N. I., By`chkova O.Yu. Khronicheskij pankreatit. Medicus Amicus. 2011. N.7. URL: https://www.medicusamicus.com/index.php?action=1x2372x1.
Shapovalov (Jr.) V., Gudzenko A., Komar L. et al. Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines. Pharmacia. 2017. Vol. 65. N. 2. P. 23–29. URL: http://bsphs.org/wp-content/uploads/2017/07/Shapovalov.pdf.
Hayduchok I. The use of hepatoprotectors in the pharmacotherapy of comorbid vasculitis with cryoglobulinemic syndrome. Periodyc Naukowy Akademii Polonijnej. 2021. Vol. 44. N. 1. P. 252-262. DOI: https://doi.org/10.23856/4430. DOI: https://doi.org/10.23856/4430
Shapovalova V., Zakharchenko I. Organizational and legal approaches to reforming of the law enforcement system of Ukraine: illegal circulation of psychoactive substances and addictive dependence. 2021. SSP Modern Law and Practice. Vol. 1. N.1. P.1–22. URL: https://doi.org/10.53933/sspmlp.v1i1.20. DOI: https://doi.org/10.53933/sspmlp.v1i1.20
Makhov V.M. Akogol`naya bolezn` pecheni i podzheludochnoj zhelezy`. Praktikuyushhij vrach. 2004. N. 1. P. 12-19.
Shapovalov (Jr.) V., Zbrozhek S., Gudzenko A., Shapovalova V., Shapovalov V. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. N.1. July-August 2018. Article N. 18, P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.
Belousov Yu.V. Komorbidnost` pri zabolevaniyakh pishhevaritel`noj sistemy`. Zdorov`e rebenka. 2012. Vol. 36. N. 1. P. 134–136.
Carvalho A.K., Menezes A.M., Camelier A. et al. Prevalence of self-reported chronic diseases in individuals over the age of 40 in São Paulo, Brazil: the platino study. Cad. Saude Publica. 2012. Vol. 28. N. 5. P. 905–912. DOI: https://doi.org/10.1590/S0102-311X2012000500009
Boyd C.M., Darer J., Boult C. et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005. Vol. 294. N. 6. P. 716–724. DOI: https://doi.org/10.1001/jama.294.6.716
Caughey G.E., Vitry A.I., Gilbert A.L., Roughead E.E. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health. 2008. N.8. P.221. DOI: https://doi.org/10.1186/1471-2458-8-221
Coebergh J.W., Janssen-Heijnen M.L., Post P.N., Razenberg P.P. Seriou’s co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996. J. Clin. Epidemiol. 1999. Vol. 52. N. 12. P. 1131–1136. DOI: https://doi.org/10.1016/S0895-4356(99)00098-0
Dawes M. Co-morbidity: we need a guideline for each patient not a guideline for each disease. Fam. Pract. 2010. Vol. 27. N. 1. P. 1–2. DOI: https://doi.org/10.1093/fampra/cmp106
Fortin M., Bravo G., Hudon C. et al. Prevalence of multimorbidity among adults seen in family practice. Ann. Fam. Med. 2005. Vol. 3. N. 3. P. 223–228. DOI: https://doi.org/10.1370/afm.272
Shapovalov V.V. (Jr.), Zbrozhek S.I., Shapovalova V.O. et al. Organizational and legal evaluation of availability of medicines’ circulation for cancer patients. Pharmacia. 2018. Vol.65. N.2. P.17-22. URL: http://bsphs.org/?magasine=organizational-and-legal-evaluation-of-availability-of-medicines-circulation-for-cancer-patients.
Shapovalov (Jr.) V., Gudzenko A., Shapovalova V. Et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of narcotic psychoactive substances in Ukraine (retrospective aspect). International Journal of Pharmaceutical Sciences and Research. 2018. Vol. 3. Is. 3. P. 22-25. URL: http://www.pharmacyjournal.net/archives/2018/vol3/issue3.
Shapovalova V.A., Shapovalov V.V. The clinical efficacy of the combined drug agent Valcophen in children. Likars'ka sprava. 1999. N. 1. P. 124–126.
Shapovalova V.O., Mykhailov V.S., Shapovalov V.V. The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic-a butyrophenone derivative-in experiments on mice. Fiziolohichnyi zhurnal. 1999. Vol.45. N.3. P. 114–117.
Uspenskyi Yu.P., Pakhomova Y.H. Syndrom abdominalnoho boliu u hastroenterolohichnii praktytsi (analiz problemy). Klyn. persp. hastroenter. hepat. 2007. N. 5. P. 21-31.
Maev I.V., Kucheryavy`j Yu.A., Sviridova A.V. Vozmozhnosti farmakoterapii v kupirovanii bolevogo abdominal`nogo sindroma u bol`nikh khronicheskim pankreatitom. E`ksper. i klinich. gastroe`nterol. 2007. N. 6. P.103-109.
Campbell-Scherer D. Multimorbidity: a challenge for evidence-based medicine. Evid. Based Med. 2010. Vol. 15. N. 6. P. 165–166. DOI: https://doi.org/10.1136/ebm1154
Shapovalova V.O., Shapovalov V.V. Spasmophilia in children and the anticonvulsant properties of a new Ukrainian preparation containing a pyrimidine derivative. Fiziolohichnyi zhurnal. 1998. Vol. 44. N. 5-6. P. 102–105. DOI: https://doi.org/10.1049/ir:19980309
Simanenkov V.I., Knorring G. Vozvrashhayas` k probleme khronicheskogo pankreatita. Klin. Med. 2001. Vol. 79. N. 10. P. 54-59.
Caughey G.E., Ramsay E.N., Vitry A.I. et al. Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. J. Epidemiol. Community Health. 2010. Vol. 64. N. 12. P. 1036–1042. DOI: https://doi.org/10.1136/jech.2009.088260
Shapovalova V.O., Chernykh V.P. The physiological properties of the action of a new analgesic and antipyretic preparation. Fiziolohichnyi zhurnal. 1997. Vol. 43. N. 1-2. P. 117–121.
Shapovalov V.V. (Jr.), Shapovalova V.A., Shapovalov V.V. Development of forensic and pharmaceutical researches within the organization of pharmaceutical business, drug technology and pharmaceutical law in Ukraine concerning the turnover of controlled drugs and substances. Health of Society. 2021. Vol. 10. N. 3. P. 98-106. DOI: https://doi.org/10.22141/2306-2436.10.3.2021.246351. DOI: https://doi.org/10.22141/2306-2436.10.3.2021.246351
Chuiev Y., Shapovalova V. Integrated ABC/VEN-analysis of drug prescriptions in pharmacotherapeutic schemes for relief of drunken forms of alcohol dependence. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. N. 1. P. 1-14. URL: https://doi.org/10.53933/sspmpm.v2i1.35. DOI: https://doi.org/10.53933/sspmpm.v2i1.35
Shapovalov V.V., Gudzenko A.A., Shapovalova V.А. et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of psychoactive substances in Ukraine. Klin.inform.telemed. 2020. Vol. 15, Iss. 16. P. 125-128. URL: https://doi.org/10.31071/kit2020.16.02. DOI: https://doi.org/10.31071/kit2020.16.02
Caughey G.E., Roughead E.E. Multimorbidity research challenges: where to go from here? Journal of Comorbidity. 2011. N. 1. P. 8–10. DOI: https://doi.org/10.15256/joc.2011.1.9
Shapovalova V.A., Zbrozhek S.I., Shapоvalov V.V. et al. Coronavirus disease pandemia 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences. 2020. Vol. 4. Issue 7. P. 61 – 68. DOI: https://doi.org/10.31080/ASPS.2020.04.0559
Babinets L.S. Porushennia ekskretornoi funktsii pidshlunkovoi zalozy yak faktor formuvannia mineralnoi nedostatnosti pry khronichnomu pankreatyti. Ukr. morfol. almanakh. 2006. N.2. P.7-10 (In Ukrainian)
Shapovalova V., Shapovalov V., Negretsky S. Forensic and pharmaceutical problems concerning circulation of cannabis: perspectives of state control, medical and narcological health effects. Actual problem of medicine and pharmacy. 2020. Vol. 1 No. 1-2. URL: https://apmplmi.com/index.php/apmp/article/view/17.
Shapovalova V.O., Sosin I.K., Shapovalov V.V. et al. Rezhym kontroliu fitopreparativ pry alkoholnomu urazhenni pidshlunkovoi zalozy : informatsiinyi lyst pro novovvedennia. K.: Ukrmedpatentinform MOZ Ukrainy, 2017. N. 244–2017. 4 p.
Hayduchok I. Supportive pharmacotherapy for systemic autoimmune diseases with hyperimmunocomplex syndrome (experimental research). Georgian medical news. 2021. N. 9 (318). P. 159-165.
Hayduchok І., Shapovalov В. Covid-19: multidisciplinary researches of forensic and pharmaceutical risks and causal relationships of unqualified medical care for patients during pandemic. 2022. SSP Modern Law and Practice. Vol.2. N.1. P.1-25. URL: https://doi.org/10.53933/sspmlp.v2i1.39. DOI: https://doi.org/10.53933/sspmlp.v2i1.39
Shapovalova V.O., Shapovalov V.V., Khalin M.M. et al. Farmatsevtychne pravo v bezpechnomu samolikuvanni. Likarski zasoby, yaki vidpuskaiutsia bez retsepta likaria. Kh.: «Skorpion», 2010.1200 p.
Lobas E.V. Rezul`taty` lecheniya bol`ny`kh sochetanny`mi khronicheskimi alkogol`ny`mi zabolevaniyami pecheni i podzheludochnoj zhelezy`, kombinacziej czitrarginina i atoksila. Gastroenterologi`ya. 2006. N. 37. P. 534–538.
Shapovalova V.O., Shekera O.H., Hudzenko A.O. et al. Rezhym kontroliu likarskykh zasobiv dlia farmakoterapii khronichnoho pankreatytu: informatsiinyi lyst pro novovvedennia. K.: Ukrmedpatentinform MOZ Ukrainy, 2018. №289–2018. 6 p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ihor Hayduchok, Iryna Tukhar, Valerii Shapovalov
This work is licensed under a Creative Commons Attribution 4.0 International License.
